GSE92921Prognostic Model for Stage II/III Colon Cancer Based on Gene Expression Subtypes and KRAS Mutation Status
Homo sapiens
59 Downloadable Samples
Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)Submitter Supplied Information
Description
The purpose of this study was to establish a new prognostic model for stage II/III colon cancer. Using public DNA microarray data of colon cancer patients, we created an integrated prognostic model for classifying the patients into high- and low-risk groups based on the expression levels of 55 genes and the KRAS mutation status.
PubMed ID
No associated PubMed ID
Publication Title
No associated publication
Total Samples
59
Submitter’s Institution
Authors
No associated authors
Source Repository
Alternate Accession IDs
Samples
Show of 0 Total Samples
Filter
Add/Remove
Accession Code
Title
Disease
Disease stage
Processing Information
Additional Metadata
Loading...
Some fields may be harmonized. Learn more